Dr. Jordan S. Orange

Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms. Among the disorders he has described and/or found major mechanistic insight are PLAID—an immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. Dr. Milner graduated with an SB in biology from the Massachusetts Institute of Technology (MIT) in 1995 and an MD with distinction in immunology from the Albert Einstein College of Medicine. He completed his residency in pediatrics at the Children’s National Medical Center in Washington, DC, and, as the recipient of the Pediatric Scientist Development Program Fellowship, did his fellowship in allergy and immunology at NIAID. He completed a postdoctoral fellowship with Dr. William E. Paul, NIAID, examining issues of mouse T-cell receptor repertoires before beginning as an investigator in the Laboratory of Allergic Diseases in the NIAID, where he was eventually named chief.Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all patients with allergic disease—rare and common, severe and mild. This is achieved by performing genetic sequencing on samples from patients with allergic disease of all sorts, as well as performing functional studies on the same patient samples, which together help point to specific immune pathways that may be fundamentally causing disease. This comprehensive analysis, when performed in larger populations, will help personalize medicine so that patients can be better categorized for targeted care. Furthermore, this type of research and care requires a coordinated and comprehensive interdisciplinary approach, taking advantage of the expertise across the department of pediatrics and at multiple outpatient sites. Dr. Milner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Hyper IgE Syndrome, Hyper IgE Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), and Hereditary Alpha-Tryptasemia. Dr. Milner is board certified in Allergy And Immunology. Dr. Milner is currently accepting new patients.

Elaine Pereira is a Medical Genetics specialist and a Pediatrics provider practicing medicine in New York, New York. Dr. Pereira is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Chromosome 6q Deletion, Trisomy 13, Chromosome 13q Duplication, and Micrognathia.

Jaya Ganesh is a Pediatrics provider practicing medicine in New York, New York. Dr. Ganesh is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Pompe Disease, and Fabry Disease.

Dr. Benjamin D. Roye, is a pediatric orthopedic surgeon specializing in complex pediatric spinal disorders including scoliosis, kyphosis, and spondylolisthesis. In addition to spinal disorders, he also manages skeletal trauma and complex fractures. After receiving his medical degree from Columbia University Vagelos College of Physicians and Surgeons, Dr. Roye completed residency training in orthopedic surgery at NewYork-Presbyterian/Columbia University Irving Medical Center. He then went on to complete a fellowship in pediatric orthopedics at Children’s Hospital of Philadelphia. To further his career as a clinician scientist, Dr. Roye also received a master’s degree in Public Health from the Columbia University Mailman School of Public Health.In addition to his clinical practice, Dr. Roye maintains an active research portfolio, specifically focusing on conservative management of scoliosis and early onset scoliosis. He is a member of the Pediatric Spine Study Group and the Harms Study Group, two of the most important spinal deformity study groups in the world. Dr. Roye has authored numerous peer-reviewed articles and is a recipient of many prestigious grants and awards, including the Arthur H. Huene Memorial Award and the Scoliosis Research Society Young Investigator Award. Outside of his practice, Dr. Roye is a workout enthusiast and competitive swimmer who most enjoys spending time with his wife, who is a practicing pediatrician, their four children, and two dogs. Dr. Roye is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Scoliosis, Kyphosis, Cerebral Palsy, Spinal Fusion, and Rhizotomy. Dr. Roye is board certified in Orthopedic Surgery. Dr. Roye is currently accepting new patients.

Robert Desnick is a Medical Genetics specialist and a Pediatrics provider practicing medicine in New York, New York. Dr. Desnick is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hereditary Coproporphyria, Fabry Disease, Aplasia Cutis Congenita, and Ectodermal Dysplasias.

"Monica Bhatia, MD specializes in the care of children with noncancerous blood disorders who may benefit from bone marrow transplantation, especially sickle cell anemia. She and her colleagues are working to reduce the toxicity (side effects) and complications of this treatment without compromising its effectiveness, and to make it available to more patients. The field of pediatric hematology brings with it many intellectual challenges, and bone marrow transplantation in particular is especially dynamic. Dr. Bhatia has the opportunity to provide care for the sickest children, potentially curing their disease. She builds strong relationships with her patients and their families that last for years. It is inspiring for her to see young patients grow up to lead healthy, productive lives. NewYork-Presbyterian/Morgan Stanley Children's Hospital has a robust program for bone marrow transplantation for sickle cell anemia - the only cure for this disease. Dr. Bhatia and her team have witnessed remarkable results among children who are cured with bone marrow transplantation and spared from the potentially life-threatening complications of sickle cell disease. Yet despite the advances made, only 15 percent of patients with sickle cell disease have a matched sibling bone marrow donor. Therefore, Dr. Bhatia and her team conduct research to evaluate a procedure called ""CD34-selected stem cell transplantation"" to remove T-cells from donor bone marrow for patients without a matched sibling donor. This approach reduces the risk of graft-versus-host disease (GVHD), a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach to harnessing stem cells could potentially make bone marrow transplantation a safer, effective option for many patients who are seeking a cure for sickle cell disease. Dr. Bhatia and her colleagues are currently assessing reduced-intensity transplantation, which uses lower doses of chemotherapy to decrease the risk of side effects and long-term complications without lowering the effectiveness of treatment. She is also interested in looking for ways to further improve the quality of life of patients who have had a bone marrow transplant in addition to fertility preservation.". Dr. Bhatia is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Hemoglobinopathy, Anemia, Chronic Graft Versus Host Disease (cGvHD), and Childhood Acute Myeloid Leukemia. Dr. Bhatia is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Bhatia is currently accepting new patients.